These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 443465)

  • 1. Variable attenuation of amphetamine effects by lithium.
    Angrist B; Gershon S
    Am J Psychiatry; 1979 Jun; 136(6):806-10. PubMed ID: 443465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment.
    Van Kammen DP; Murphy DL
    Psychopharmacologia; 1975 Nov; 44(3):215-24. PubMed ID: 1824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
    van Kammen DP; Docherty JP; Marder SR; Rosenblatt JE; Bunney WE
    Psychopharmacology (Berl); 1985; 87(1):111-5. PubMed ID: 3933028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.
    Gould TD; O'Donnell KC; Picchini AM; Manji HK
    Neuropsychopharmacology; 2007 Jun; 32(6):1321-33. PubMed ID: 17151598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients.
    Buchsbaum MS; van Kammen DP; Murphy DL
    Psychopharmacology (Berl); 1977 Jan; 51(2):129-35. PubMed ID: 402663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium.
    Beckmann H; van Kammen DP; Goodwin FK; Murphy DL
    Biol Psychiatry; 1976 Aug; 11(4):377-87. PubMed ID: 786381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
    Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
    Rosenblatt JE; Lake CR; van Kammen DP; Ziegler MG; Bunney WE
    Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral effects of lithium on amphetamine-induced hyperactivity in rats.
    Smith DF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):439-42. PubMed ID: 6262841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new psychotropic agent. Psychological and physiological effects of 2,5-dimethoxy-4-ethyl amphetamine (DOET) in man.
    Snyder SH; Faillace LA; Weingartner H
    Arch Gen Psychiatry; 1969 Jul; 21(1):95-101. PubMed ID: 4389442
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol.
    Angrist B; Sanfilipo M; Wolkin A
    Clin Neuropharmacol; 2001; 24(3):139-44. PubMed ID: 11391124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of setting on the subjective and behavioral effects of d-amphetamine in humans.
    Zacny JP; Bodker BK; de Wit H
    Addict Behav; 1992; 17(1):27-33. PubMed ID: 1595423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of fenfluramine and amphetamine in man.
    Griffith JD; Nutt JG; Jasinski DR
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):563-70. PubMed ID: 1102234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
    Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH
    Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol and D-amphetamine upon mood and volition.
    Hurst PM; Radlow R; Chubb NC; Bagley SK
    Psychol Rep; 1969 Jun; 24(3):975-87. PubMed ID: 5809087
    [No Abstract]   [Full Text] [Related]  

  • 17. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
    Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
    Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorphins, lithium, and naloxone: their relationship to pathological and drug-induced manic-euphoric states.
    Gold MS; Byck R
    NIDA Res Monogr; 1978; (19):192-209. PubMed ID: 218105
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.